EIKN
HEALTHCAREEikon Therapeutics Inc
$9.97-0.31 (-3.02%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving EIKN Today?
No stock-specific AI insight has been generated for EIKN yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$7.90$17.40
$9.97
Fundamentals
Market Cap$540M
P/E Ratio—
EPS$-6.18
Dividend Yield—
Dividend / Share—
ROE-1.3%
Profit Margin—
Debt / Equity—
Trading
Volume230K
Avg Volume (10D)—
Shares Outstanding54.1M
EIKN News
3 articles- Eikon Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Clinical and Corporate UpdatesYahoo Finance·Mar 30, 2026
- Spotify upgraded, First Solar downgraded: Wall Street's top analyst callsYahoo Finance·Feb 26, 2026
- Eikon Therapeutics Announces Pricing of Upsized Initial Public OfferingYahoo Finance·Feb 5, 2026
All 3 articles loaded
Price Data
Open$10.42
Previous Close$10.28
Day High$10.76
Day Low$9.94
52 Week High$17.40
52 Week Low$7.90
52-Week Range
$7.90$17.40
$9.97
Fundamentals
Market Cap$540M
P/E Ratio—
EPS$-6.18
Dividend Yield—
Dividend / Share—
ROE-1.3%
Profit Margin—
Debt / Equity—
Trading
Volume230K
Avg Volume (10D)—
Shares Outstanding54.1M
About Eikon Therapeutics Inc
Eikon Therapeutics, Inc., is a clinical biopharmaceutical company in the United States. The company is headquartered in Millbrae, California.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—